>全球聚乙二醇化蛋白质治疗市场，按产品类型（集落刺激因子、干扰素、促红细胞生成素 (EPO)、重组因子 VIII、单克隆抗体、酶、其他）、治疗领域（肿瘤学、皮肤病学、胃肠病学等）、适应症（癌症、胃肠道疾病、肝炎、自身免疫性疾病、血友病、多发性硬化症、实体瘤、其他）、药物（培非格司亭、培加达姆塞、培门冬酶、培维索孟、其他）、给药途径（口服、注射）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、零售药房）、国家（美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、南非韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区）行业趋势和预测至 2028 年。
市场分析与洞察：全球聚乙二醇化蛋白质治疗市场
聚乙二醇化蛋白质治疗市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 6.9%。
聚乙二醇化是指附着聚乙二醇的生化过程，它通过基因改造帮助治疗慢性病。它具有多种益处，例如减少给药频率、提高药物溶解度和增加药物稳定性，从而推动了其在市场的需求。
许多制药行业正在进行的临床试验以及对疾病特异性新疗法的大量需求预计将在预测期内进一步加速聚乙二醇化蛋白质治疗市场的整体增长。除此之外，监管机构的特殊指定增加也有望促进市场的整体增长。然而，许多制药公司针对性疗法的研发营业收入机会有限，以及一些发展中国家的医疗预算较低，这些因素预计将最有可能阻碍未来几年聚乙二醇化蛋白质治疗市场的增长。
此外，市场竞争格局和战略合作将在不久的将来为聚乙二醇化蛋白质治疗市场的增长提供更多机遇。然而，品牌药物的专利到期和仿制药的推出可能会阻碍市场的增长，这可能是预测期内的挑战因素之一。
This PEGylated protein therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on PEGylated protein therapeutics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global PEGylated Protein Therapeutics Market Scope and Market Size
The PEGylated protein therapeutics market is segmented on the basis of product type, therapeutic area, indication, drugs, route of administration and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the product type, the PEGylated protein therapeutics market is segmented into colony stimulating factor, interferon, erythropoietin (EPO), recombinant factor VIII, monoclonal antibody, enzyme and others.
- On the basis of therapeutic area, the market is bifurcated into oncology, dermatology, gastroenterology and others.
- On the basis of indication, the PEGylated protein therapeutics market is segmented into cancer, gastrointestinal disorder, hepatitis, autoimmune disorders, hemophilia, multiple sclerosis, solid tumors ad others.
- On the basis of drugs, the market is segmented into pegfilgrastim, pegadamese, pegaspargase, pegvisomant and others
- On the basis of route of administration, the PEGylated protein therapeutics market is segmented into oral and injectable.
- On the basis of distribution channel, the market is segmented into hospital pharmacies and retail pharmacies.
PEGylated Protein Therapeutics Market Country Level Analysis
The PEGylated protein therapeutics market is analyzed and market size insights and trends are provided by product type, therapeutic area, indication, drugs, route of administration and distribution channel as referenced above.
The countries covered in the PEGylated protein therapeutics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the PEGylated protein therapeutics market owing to the growing prevalence of cancer, availability of advanced treatment, presence of well-developed healthcare infrastructure and funding from public and private sectors for research and development are projected within the region. Asia Pacific, on the other hand, is projected to observe significant amount of growth in the PEGylated protein therapeutics market because the high prevalence of chronic and rare diseases and increasing government and public sectors support for developing effective and novel therapeutics.
The country section of the PEGylated protein therapeutics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and PEGylated Protein Therapeutics Market Share Analysis
The PEGylated protein therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to PEGylated protein therapeutics market.
聚乙二醇化蛋白质治疗市场报告中涉及的主要参与者包括 Enzon Pharmaceuticals, Inc、F. Hoffmann-La Roche Ltd、Takeda Pharmaceutical Company Limited、Affymax, Inc、Novo Nordisk A/S、Biogen、Amgen Inc、Pfizer Inc、Teva Pharmaceutical Industries Ltd、Merck & Co., Inc、AstraZeneca、Nektar Technology, Inc、Leadiant Biosciences. Inc、UCB SA、Horizon Therapeutics plc、Eiger BioPharmaceuticals、Halozyme, Inc、Biocad、PharmaEssentia Corporation 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
